Research programme: iT cell therapies - Century Therapeutics
Latest Information Update: 20 May 2024
At a glance
- Originator Clade Therapeutics
- Class Gene therapies; Immunotherapies; T lymphocyte cell therapies
- Mechanism of Action Immunologic cytotoxicity; T lymphocyte replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Solid tumours
Most Recent Events
- 17 May 2024 Early research in Solid tumours in USA (Parenteral) (Century Therapeutics pipeline, May 2024)